Onetrela 50 Tablets 4s Pack Pack

Onetrela 20 Tablet is a medication manufactured by Alkem Laboratories Ltd., designed to manage type 2 diabetes mellitus. Each tablet contains Trelagliptin 20 mg, a potent dipeptidyl peptidase-4 (DPP-4) inhibitor.

Uses

Onetrela 20 Tablet is primarily used for improving glycemic control in adults with type 2 diabetes mellitus. It is used as an adjunct therapy to diet and exercise.

Mechanism of Action

Trelagliptin, the active ingredient, inhibits the DPP-4 enzyme. This inhibition leads to increased levels of incretin hormones such as GLP-1 and GIP. These hormones enhance insulin secretion in response to meals and decrease glucagon levels, thereby improving blood glucose control.

Dosage and Administration

The usual prescribed dose is one tablet daily, taken with or without food. It’s recommended to take the tablet at the same time each day to maintain consistent blood levels. Dosage adjustments may be necessary based on individual patient needs and response to treatment.

Precautions and Contraindications

Avoid use if allergic to Trelagliptin or any components of the tablet. Caution is advised in patients with kidney issues. Consult a healthcare provider before use during pregnancy or breastfeeding. Inform your doctor about all other medications being taken, as Trelagliptin may interact with other drugs.

Potential Side Effects

While Trelagliptin is generally well-tolerated, some individuals may experience nausea, diarrhea, headache, dizziness, or upper respiratory tract infections. Most side effects are mild and transient. If any adverse reactions persist or worsen, consult a healthcare professional promptly.

Availability

Onetrela 20 Tablet is available in a pack of 20 tablets. Pricing and availability may vary based on location and retailer.

Note

Always use Onetrela 20 Tablet under the supervision of a healthcare provider. Adherence to prescribed dosage and lifestyle modifications, including diet and exercise, are crucial for optimal management of type 2 diabetes mellitus.